A citation-based method for searching scientific literature

Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
Times Cited: 1197



Thomas A Wynn. J Exp Med 2011
Times Cited: 789




List of shared articles



Times cited

Iron-Dependent Mitochondrial Dysfunction Contributes to the Pathogenesis of Pulmonary Fibrosis.
Mai Takahashi, Kenji Mizumura, Yasuhiro Gon, Tetsuo Shimizu, Yutaka Kozu, Sotaro Shikano, Yuko Iida, Mari Hikichi, Shinichi Okamoto, Kota Tsuya,[...]. Front Pharmacol 2022
3

Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols.
Harshank Patel, Jui Rakesh Shah, Divya Rakeshkumar Patel, Chaithanya Avanthika, Sharan Jhaveri, Kunj Gor. Dis Mon 2022
0

Diosgenin inhibits TGF-β1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis.
Vadivel Dinesh Babu, Anandasadagopan Suresh Kumar, Ganapasam Sudhandiran. Drug Chem Toxicol 2022
4

Idiopathic pulmonary fibrosis: Current and future treatment.
Daniel S Glass, David Grossfeld, Heather A Renna, Priya Agarwala, Peter Spiegler, Joshua DeLeon, Allison B Reiss. Clin Respir J 2022
9

Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.
Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou. Oxid Med Cell Longev 2022
0


Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis.
Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, Qinjie Weng. Acta Pharm Sin B 2022
10